| 1. |
Surgery: Clinical Studies Open For Enrollment Post-Market Registry in Europe and US for the Use of VascuCel A Phase 3, Prospective, Randomized, Open-label, Adaptive Group Sequential, Multicenter Trial with Blinded Endpoint Assessment to Evaluate the Efficacy and Safety of PROTHROMPLEX TOTAL for the Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation in Patients Requiring Urgent Surgery/Invasive Procedure. Profiling of plasma before and after anticoagulant therapy in patients diagn...
- Site Map Content
- 4/11/2025
|
| 2. |
Hematology: Clinical Studies Open For Enrollment Allogeneic Stem Cell Transplant to Induce Mixed Donor Chimerism in Patients with Sickle Cell Disease & Thalassemia NYMC 556 A prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children with SCID Disorders The use of dose dense rituximab for high risk patients with newly diagnosed acute immune thrombocytopenic purpura A Pilot Study to Determine the Safety of Defibrotide in Children with High Risk Kawasaki Disease (NYMC-204) NYMC...
- Site Map Content
- 1/30/2025
|
| 3. |
Welcome! Please View Our Campus Tour
- Site Map Content
- 10/3/2024
|
| 4. |
Cardiology: Clinical Studies Open For Enrollment PROTOCOL CY 6022 AN OPEN-LABEL STUDY OF CK3773274 FOR PATIENTS WITH SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY (HCM) Observational Study Protocol CV027-012 DELIVER INSIGHTS IN HYPERTROPHIC CARDIOMYOPATHY AND OBSERVATIONAL OUTCOMES IN REAL WORLD (DISCOVER-HCM): UNITED STATES PROSPECTIVE REGISTRY STUDY A multi-center, randomized, double-blind, placebo-controlled, parallel-group Phase IIIb study evaluating the effect of inclisiran on atherosclerotic plaque prog...
- Site Map Content
- 2/26/2025
|
| 5. |
Oncology: Clinical Studies Open For Enrollment Lymphoma Leukemia Solid Tumors Brain Tumors Urology Radiation Medicine Transplants Myeloma Sarcoma Lymphoma Immunochemotherapy with Obinutuzumab, Ifosfamide, Carboplatin and Etoposide (O-ICE) in CAYA with recurrent refractory CD20+ Mature B-NHL Pilot Study Using Induction Chemo-immunotherapy followed by Consolidation with Reduced Toxicity Conditioning and Allogenic Stem Cell Transplant in Advanced Stage Mature Non-anaplastic T-Cell or N...
- Site Map Content
- 4/3/2025
|